Cooper DA - Search Results

1

Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group.

Ashton LJ, Carr A, Cunningham PH, Roggensack M, McLean K, Law M, Robertson M, Cooper DA, Kaldor JM. Ashton LJ, et al. Among authors: cooper da. AIDS Res Hum Retroviruses. 1998 Jan 20;14(2):117-21. doi: 10.1089/aid.1998.14.117. AIDS Res Hum Retroviruses. 1998. PMID: 9462921

2

Long-term symptomless HIV-1 infection in recipients of blood products from a single donor.

Learmont J, Tindall B, Evans L, Cunningham A, Cunningham P, Wells J, Penny R, Kaldor J, Cooper DA. Learmont J, et al. Among authors: cooper da. Lancet. 1992 Oct 10;340(8824):863-7. doi: 10.1016/0140-6736(92)93281-q. Lancet. 1992. PMID: 1357294

3

The role of initial AIDS-defining illness in survival following AIDS.

Luo K, Law M, Kaldor JM, McDonald AM, Cooper DA. Luo K, et al. Among authors: cooper da. AIDS. 1995 Jan;9(1):57-63. doi: 10.1097/00002030-199501000-00008. AIDS. 1995. PMID: 7893442

4

Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection.

Kelleher AD, Emery S, Cunningham P, Duncombe C, Carr A, Golding H, Forde S, Hudson J, Roggensack M, Forrest BD, Cooper DA. Kelleher AD, et al. Among authors: cooper da. AIDS Res Hum Retroviruses. 1997 Jan 1;13(1):29-32. doi: 10.1089/aid.1997.13.29. AIDS Res Hum Retroviruses. 1997. PMID: 8989424 Clinical Trial.

5

Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group.

Stewart GJ, Ashton LJ, Biti RA, Ffrench RA, Bennetts BH, Newcombe NR, Benson EM, Carr A, Cooper DA, Kaldor JM. Stewart GJ, et al. Among authors: cooper da. AIDS. 1997 Dec;11(15):1833-8. doi: 10.1097/00002030-199715000-00007. AIDS. 1997. PMID: 9412701

6

Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group.

Kaufmann GR, Cunningham P, Kelleher AD, Zaunders J, Carr A, Vizzard J, Law M, Cooper DA. Kaufmann GR, et al. Among authors: cooper da. J Infect Dis. 1998 Dec;178(6):1812-5. doi: 10.1086/314480. J Infect Dis. 1998. PMID: 9815241

7

HIV disease progression in Australia in the time of combination antiretroviral therapies.

Correll PK, Law MG, McDonald AM, Cooper DA, Kaldor JM. Correll PK, et al. Among authors: cooper da. Med J Aust. 1998 Nov 2;169(9):469-72. Med J Aust. 1998. PMID: 9847898

8

AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment.

Law MG, de Winter L, McDonald A, Cooper DA, Kaldor JM. Law MG, et al. Among authors: cooper da. AIDS. 1999 Feb 4;13(2):263-9. doi: 10.1097/00002030-199902040-00015. AIDS. 1999. PMID: 10202833

9

Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.

Zaunders JJ, Geczy AF, Dyer WB, McIntyre LB, Cooley MA, Ashton LJ, Raynes-Greenow CH, Learmont J, Cooper DA, Sullivan JS. Zaunders JJ, et al. Among authors: cooper da. AIDS Res Hum Retroviruses. 1999 Nov 20;15(17):1519-27. doi: 10.1089/088922299309801. AIDS Res Hum Retroviruses. 1999. PMID: 10580402

10

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM. Grulich AE, et al. Among authors: cooper da. AIDS. 2000 Jan 28;14(2):133-40. doi: 10.1097/00002030-200001280-00008. AIDS. 2000. PMID: 10708283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

830 results

Search Page

Filters